Side effects of treatment with I-131-meta-iodobenzylguanidine (I-131-MIBG) in neuroblastoma patients.
Voûte
P A
PA
Werkgroep Kindertumoren, Emma Kinderziekenhuis, Amsterdam, The Netherlands.
Hoefnagel
C A
CA
de Kraker
J
J
Majoor
M
M
D019797:3-Iodobenzylguanidine; D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D001859:Bone Neoplasms / Q000556:secondary; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007462:Iodobenzenes / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine